跳至主要内容
临床试验/NCT02641925
NCT02641925Unknown不适用

The Effect of Visceral Fat Removal for Gastric Cancer Patients With Metabolic Syndrome, Randomized Pilot Study: Omentectomy for Metabolic Syndrome (OMS)

Keimyung University Dongsan Medical Center6 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2015年8月最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
试验地点
6
主要终点
HOMA-IR change

研究概览

简要总结

Many features of the metabolic syndrome are associated with insulin resistance. And, metabolic syndrome and insulin resistance are related to visceral obesity. Therefore, the investigators hypothesized that visceral fat removal (omentectomy) can make favorable results for the insulin resistance and metabolic syndrome. As the omentectomy is optional procedure during a surgery for early gastric cancer, the investigators will divide patients randomly into two groups, total omentectomy group and omentum preserving group.

详细描述

The investigators will compare the change of insulin resistance (HOMA-IR) and improvement of metabolic syndrome between total omentectomy and omentum preserving group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Histologically confirmed adenocarcinoma in stomach
  • Aged≥20 years and ≤80 years
  • Scheduled as laparoscopic distal gastrectomy (cT1N0M0 or cT2N0M0)
  • Metabolic syndrome (NCEP:ATP III (National Cholesterol Education Program and Adult Treatment Panel III) -harmonizing definition criteria
  • ECOG 0 (Eastern Cooperative Oncology Group)
  • ASA score class I-III (American Society of Anesthesiologists)
  • patient has given their written informed consent to participate in the study

排除标准

  • Simultaneously combined resection of other organ
  • Active other malignancy
  • Expected to severe intra-abdominal adhesion due to previous abdominal operation history
  • Uncontrolled co-morbidity
  • Vulnerable patients

结局指标

主要结局

HOMA-IR change

时间窗: pre-operative and post-operative 12months

HOMA-IR change after operation

次要结局

  • prevalence of metabolic syndrome(pre-operative and post-operative 12months)
  • Complication(within 30days)
  • HOMA-IR change according to anastomosis type(pre-operative and post-operative 12months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Seung Wan Ryu

Director of Gastrointesinal surgery, associate professor

Keimyung University Dongsan Medical Center

研究点 (6)

Loading locations...

相似试验